The Use of tDCS for Vaping Reduction — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Use of tDCS for Vaping Reduction — Stella

View on ClinicalTrials.gov

Recruiting

Back to Vaping trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Centre for Addiction and Mental Health, Toronto, Ontario

Key details

Sponsor

Centre for Addiction and Mental Health

Enrollment target

~40 participants

Started

January 2026

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.